the effect of misoprostol with and without letrozole in successful Induction of medical abortion and its relation with BHCG titrage and cervical length

Gorgan University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新: 2020年8月17日

试验速览

暂无简介。

•Pregnant women candidates for termination of pregnancy under 18 weeks of gestation
•Missed abortions
•Legal and medical abortions
•Single pregnancy
•Hemoglobin level> 10 g/ l
•There should be no history or evidence of adrenal pathology, malignancies, porphyria, thromboembolism, severe or recurrent liver disease, or gestational pruritus
•Being consent to participate in the study

•Any sensitivity to misoprostol and letrozole
•Having an intrauterine device
•Having a history of more than 2 cesarean sections
•Any abnormalities in pre-treatment blood tests, including CBC, liver and abnormalities in kidney function tests, including blood urea, creatinine, albumin, globulin, liver enzymes, and electrolytes
•Specific medical conditions such as severe anemia, coagulation disorders, active liver disease, cardiovascular disease, glaucoma, and uncontrolled seizure disorders
•Having a history of thromboembolism, adrenal diseases, steroid-dependent cancer, porphyria, and disorders that require treatment with glucocorticoids, such as bronchial asthma

发起方

Gorgan University of Medical Sciences